Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

THC Biomed Intl Ltd. (THCBF)

Compare
0.0010
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Currency in CAD All numbers in thousands
Breakdown
TTM
7/31/2022
7/31/2021
7/31/2020
Total Revenue
2,858.5730
3,339.9970
3,774.3210
4,178.1790
Cost of Revenue
4,020.2450
4,369.6440
6,948.5820
934.2150
Gross Profit
-1,161.6720
-1,029.6470
-3,174.2610
3,243.9640
Operating Expense
1,888.4090
2,172.9280
2,761.0360
3,038.7040
Operating Income
-3,050.0810
-3,202.5750
-5,935.2970
205.2600
Net Non Operating Interest Income Expense
-622.5710
-495.1880
-421.6260
-360.8290
Other Income Expense
1.2210
631.9150
-2.3310
-6.0210
Pretax Income
-3,671.4310
-3,065.8480
-6,359.2540
-161.5900
Net Income Common Stockholders
-3,671.4310
-3,065.8480
-6,359.2540
-161.5900
Diluted NI Available to Com Stockholders
-3,671.4310
-3,065.8480
-6,359.2540
-161.5900
Basic EPS
-0.02
-0.02
-0.04
-0.00
Diluted EPS
-0.02
-0.02
-0.04
-0.00
Basic Average Shares
163,938.6560
163,902.3920
163,565.5710
156,081.5940
Diluted Average Shares
163,938.6560
163,902.3920
163,565.5710
156,081.5940
Rent Expense Supplemental
--
--
--
5.0790
Total Expenses
5,908.6540
6,542.5720
9,709.6180
3,972.9190
Interest Income
6.0780
5.9700
0.1290
0.0580
Interest Expense
628.6490
501.1580
421.7550
360.8870
Net Interest Income
-622.5710
-495.1880
-421.6260
-360.8290
Net Income from Continuing & Discontinued Operation
-3,671.4310
-3,065.8480
-6,359.2540
-161.5900
Normalized Income
-3,673.1880
-3,697.4840
-6,355.7550
-154.7810
EBIT
-3,042.7820
-2,564.6900
-5,937.4990
199.2970
EBITDA
-2,026.2100
-1,636.1530
-4,957.5420
1,213.6530
Reconciled Cost of Revenue
3,864.8290
4,369.6440
6,948.5820
934.2150
Reconciled Depreciation
1,016.5720
928.5370
979.9570
1,014.3560
Net Income from Continuing Operation Net Minority Interest
-3,671.4310
-3,065.8480
-6,359.2540
-161.5900
Total Unusual Items Excluding Goodwill
1.7570
631.6360
-3.4990
-6.8090
Total Unusual Items
1.7570
631.6360
-3.4990
-6.8090
Normalized EBITDA
-2,027.9670
-2,267.7890
-4,954.0430
1,220.4620
7/31/2020 - 2/9/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers